Myrbetriq and Chantix drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Myrbetriq and Chantix. Common interactions include hyponatraemia among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people who take Myrbetriq and Chantix have. It is created by eHealthMe based on reports of 48 people who take Myrbetriq and Chantix from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
48 people who take Myrbetriq and Chantix together, and have interactions are studied.
What is Myrbetriq?
Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 23,231 Myrbetriq users for its effectiveness, alternative drugs and more.
What is Chantix?
Chantix has active ingredients of varenicline tartrate. It is often used in quit smoking. eHealthMe is studying from 87,564 Chantix users for its effectiveness, alternative drugs and more.
Number of Myrbetriq and Chantix reports submitted per year:
Common Myrbetriq and Chantix drug interactions by gender *:
- Intervertebral disc degeneration
- Lip swelling
- Loss of consciousness
- Chronic kidney disease
- Renal impairment
- Blood creatinine increased
- Decreased activity
- Spinal compression fracture
- Tubulointerstitial nephritis
Common Myrbetriq and Chantix drug interactions by age *:
- Abnormal dreams
- Central nervous system lesion
- Multiple sclerosis
- Chronic kidney disease
- Renal failure
- Ear pruritus
- Emotional distress
- Mobility decreased
- Fluid retention
- Head injury
Common conditions people have *:
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 29.17%
- Pain: 12 people, 25.00%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 20.83%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 7 people, 14.58%
- High Blood Cholesterol: 7 people, 14.58%
- Depression: 6 people, 12.50%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 10.42%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 10.42%
- Constipation: 5 people, 10.42%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Myrbetriq and Chantix?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
Browse all drug interactions of Myrbetriq and Chantix:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Myrbetriq interactions:
Browse all interactions between Myrbetriq and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Chantix interactions:
Browse all interactions between Chantix and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on mirabegron and varenicline tartrate (the active ingredients of Myrbetriq and Chantix, respectively), and Myrbetriq and Chantix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Myrbetriq and Chantix.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Sodium Chloride and Lipase Increased - now
- Doxycycline and Fractured Ischium - a second ago
- Multivitamin and Serzone drug interaction - 10 seconds ago
- Desogen and Breathing Difficulty - 15 seconds ago
- Rheumatoid Arthritis and Gastric Neoplasm - 19 seconds ago
- Adalat Cc and Oxycontin drug interaction - 23 seconds ago
- Fosinopril Sodium and Centrum Silver drug interaction - 29 seconds ago
- Lyrica and Tumor Invasion - 35 seconds ago
- Green Tea and Turmeric drug interaction - 38 seconds ago
- Hydrochlorothiazide and Conjunctival Bleb - 43 seconds ago